Please provide your email address to receive an email when new articles are posted on . OULU, Finland — Infection with Chlamydia trachomatis increases the risk of invasive cervical cancer, according ...

Sexually Transmitted Diseases, Vol. 35, No. 11, Supplement: Male Chlamydia Screening (November 2008), pp. S28-S33 (6 pages) We performed a structured literature review of published studies from ...

A vaccine for the most common sexually transmitted infection has passed an early test on the path to public availability. Health researchers in the UK have developed a potential vaccine for chlamydia, ...

The diagnostic value of different laboratory methods in detecting Chlamydia trachomatis infections in high risk groups was analysed. The efficiency of a direct specimen test was compared with serology ...

Chlamydia trachomatis is an obligate intracellular bacterium and a major cause of sexually transmitted bacterial infections worldwide. Chlamydial infections are typically asymptomatic and reinfections ...

A breakthrough in the study of chlamydia genetics could open the way to new treatments and the development of a vaccine for this sexually transmitted disease. For decades research progress has been ...

Chlamydia trachomatis remains a major global pathogen causing both ocular and genital infections, contributing significantly to public health burdens such as infertility, pelvic inflammatory disease, ...

Increased understanding of the biology and survival tactics of Chlamydia trachomatis is suggesting that the post-infectious chronic arthritis experienced by many patients may actually be curable. The ...

The obligate bacterium, Chlamydia trachomatis, is an insidious microorganism that causes the sexually-transmitted disease, Chlamydia, in humans. Infections are progressive, with undiagnosed patients ...

Chlamydia trachomatis infections are a global health problem. This obligate intracellular bacterial pathogen comprises lymphogranuloma venereum (L1–L3), ocular (A–C) and genital (D–K) serovars.

There are a number of C. trachomatis gene products that exhibit variability and may modulate disease severity (Figure 3). The major categories of variable chlamydial gene products and their roles in ...